ANIK Anika Therapeutics, Inc.: Margin operasi

Lambang korporat lan logo Anika Therapeutics Inc. (ANIK)

Under the leadership of Cheryl Blanchard, Anika Therapeutics management is optimizing assets to scale its regenerative segment. Revenues are based on the sale of high-margin hyaluronic acid products. The operating profitability trajectory on the GURU.Markets terminal chart confirms the model's resilience, with the current figure standing at -2.10. Technological development is driven by close collaboration with surgeons and sports medicine centers.

ANIK: Margin operasi Anika 04.07.2022 - 20.11.2026

Anika Therapeutics Inc. - rincian analitis lan metrik utama (ANIK)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:ANIK, Anika Therapeutics, Inc.
Produk merek Anika Therapeutics, Inc.

Operating margin measures the share of profit from core business operations before interest and taxes relative to total revenue. For Anika Therapeutics (ANIK), this metric reflects the efficiency of commercializing hyaluronic acid-based products. By analyzing the operating profit margin history, an investor assesses the sustainability of cash flow. High FDA barriers and protected distribution channels allow the company to maintain pricing power. Stable growth in this metric confirms the fundamental reliability of the capital.

Pesaing Anika Therapeutics (ANIK)

BSX (Boston Scientific Corporation Inc.) - Margin operasi|Margin operasi Edwards Lifesciences Inc.|Margin operasi RMD|Margin dodolan operasi Insulet Corporation PODD|Rentabilitas operasi Zimmer Biomet ZBH|CooperVision - Rentabilitas operasi|ALGN - Rentabilitas operasi|GMED: Rentabilitas operasi|TMDX (TransMedics Corp) - Margin dodolan operasi|Alphatec Holdings, Inc. - Tingkat bathi operasi|AORT (Artivion Corp) - Margin operasi|Rentabilitas dodolan operasi Enovis Corp ENOV|Rentabilitas operasi Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Tingkat bathi adhedhasar bathi operasi|iLet Bionic Pancreas - Margin dodolan operasi|Margin operasi IRADIMED CORPORATION IRMD|Embecta Corp - Margin operasi|Rentabilitas kegiatan operasi Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Rentabilitas operasi|Margin bathi operasi SIBN (SI-BONE Medical)|Rentabilitas operasi orthofix.com|Rentabilitas dodolan operasi bioventus.com BVS|Margin operasi KIDS|TMCI - Rentabilitas dodolan operasi|Rentabilitas operasi Strata Critical Medical Inc SRTA|CARL: Rentabilitas dodolan miturut bathi operasi|RXST: Margin dodolan operasi|clearpointneuro.com - Rasio bathi operasi|Stereotaxis Inc (STXS) - Rentabilitas operasi|Rentabilitas dodolan miturut bathi operasi STIM|SGHT (Sight Sciences Inc) - Margin operasi|OBIO: Tingkat bathi operasi|Rentabilitas operasi inspiremd.com (NSPR)|Jin Medical International Ltd - Rentabilitas dodolan miturut bathi operasi|Margin operasi VANI (Vivani Medical Inc)|XTNT: Rentabilitas dodolan miturut bathi operasi|NMTC - Rentabilitas operasi|MODD: Rentabilitas operasi|MYO: Margin operasi|envoymedical.com - Tingkat bathi operasi|Margin dodolan operasi VVOS|Rentabilitas dodolan operasi enVVeno NVNO|Margin operasi SINT|TNON - Rentabilitas dodolan operasi|Rentabilitas operasi ReWalk Robotics LFWD|AMIX: Rentabilitas dodolan miturut bathi operasi|IVF - Rentabilitas operasi|Rentabilitas dodolan operasi Bone Biologics Corp|AXNX: Margin operasi|Margin dodolan operasi BIOLASE, Inc.|Margin dodolan operasi DYNT|Margin dodolan operasi Paragon 28 (FNA)|Rentabilitas operasi INVO Bio (INVO)